Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

TCR2 THERAPEUTICS INC. (TCRR)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K8-K10-K8-K10-K10-K10-K10-K
Revenues   [+]0.098.60.073.60.00.00.09.6
            Revenue growth   34.1%    -100.0%24.5%
Cost of goods sold  0.0153.50.099.70.00.00.013.2
Gross profit  0.0-54.90.0-26.20.00.00.0-3.6
            Gross margin   -55.6% -35.6%   -37.7%
Selling, general and administrative   [+]153.524.499.722.568.713.96.83.6
Research and development       37.519.7 
Other operating expenses  -34.374.2-4.151.1-3.5  6.0
EBITDA   [+]-116.2-150.5-92.8-96.9-63.6-50.5-26.0-12.9
            EBITDA margin   -152.5% -131.7%   -134.6%
Depreciation and amortization  3.03.02.82.81.60.90.40.3
EBIT   [+]-119.2-153.5-95.6-99.7-65.2-51.4-26.5-13.2
            EBIT margin   -155.6% -135.6%   -137.7%
Non-recurring items   [+]30.4 3.7     
Interest income   1.9 0.2    
Other income (expense), net   [+]-1.9 -0.2 -1.73.92.20.1
Pre-tax income  -151.6-151.6-99.5-99.5-67.0-47.5-24.3-13.1
Income taxes  0.30.30.30.30.20.10.00.0
            Tax rate        0.0%0.0%
Net income  -151.8-151.8-99.8-99.8-67.1-97.5-61.50.0
            Net margin   -153.9% -135.6%   -0.2%
   
Basic EPS   [+]($3.93)($3.93)($2.63)($2.63)($2.40)($4.62)($98.53)($39.94)
Diluted EPS   [+]($3.93)($3.93)($2.63)($2.63)($2.40)($4.62)($98.53)($39.94)
   
Shares outstanding (basic)   [+]38.638.637.937.928.021.10.60.0
Shares outstanding (diluted)   [+]38.638.637.937.928.021.10.60.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy